The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis

被引:50
作者
Lakatos, Gabor [1 ]
Sipos, Ferenc [1 ,2 ]
Miheller, Pal [1 ]
Hritz, Istvan [1 ]
Varga, Maria Zsofia [1 ]
Juhasz, Mark [1 ]
Molnar, Bela [2 ]
Tulassay, Zsolt [1 ,2 ]
Herszenyi, Laszlo [1 ]
机构
[1] Semmelweis Univ, Dept Med 2, H-1088 Budapest, Hungary
[2] Hungarian Acad Sci, Clin Gastroenterol Res Unit, Budapest, Hungary
关键词
Matrix metalloproteinase; Ulcerative colitis; Lymphocytic colitis; Collagenous colitis; Immunohistochemistry; Inflammation; MATRIX METALLOPROTEINASES; PLASMINOGEN-ACTIVATOR; SERINE PROTEASES; CROHNS-DISEASE; CATHEPSIN-B; EXPRESSION; MUCOSA; TISSUE; BUDESONIDE; INHIBITORS;
D O I
10.1007/s12253-011-9420-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Matrix metalloproteinases play an important role in extracellular matrix remodelling. It has been proposed that matrix metalloproteinase-9 (MMP-9) is involved in epithelial damage in ulcerative colitis (UC). However, to our knowledge, no data are available in terms of MMP-9 expression in microscopic colitis. Determination of mucosal protein expression levels of MMP-9 in lymphocytic colitis (LC), collagenous colitis (CC) and UC. MMP-9 immunohistochemical expressions were analyzed in paraffin-embedded tissue samples by immunohistochemistry including patients with LC, CC, UC, active diverticulitis, inactive diverticular disease and healthy control subjects. UC was also subgrouped according to the severity of inflammation. Immunostaining was determined semiquantitatively. Independent colonic biopsies from healthy and severe UC cases were used for gene expression analyses. For further comparison MMP-9 serum antigen levels were also determined in patients with UC and control patients without macroscopic or microscopic changes during colonoscopy. MMP-9 mucosal expression was significantly higher in UC (26.7 +/- 19.5%) compared to LC (6.6 +/- 9.3%), CC (6.4 +/- 7.6%), active diverticulitis (5.33 +/- 2.4%), inactive diverticular disease (5.0 +/- 2.2%) and controls (6.3 +/- 2.6%) (P < 0.001). The immunohistochemical expression of MMP-9 in LC and CC was similar as compared to controls. MMP-9 expression was significantly higher in each inflammatory group of UC compared to controls (mild: 11.0 +/- 2.8%, moderate: 23.9 +/- 3.7%, severe UC: 52.6 +/- 3.9% and 6.3 +/- 2.6%, respectively, P < 0.005). The gene expression microarray data and RT-PCR results demonstrated a significantly higher expression of MMP-9 in severely active UC compared to healthy controls (P < 0.001). Significantly higher MMP-9 serum antigen concentrations were observed in UC patients compared with the control group (P < 0.05). MMP-9 seems to play no role in the inflammatory process of LC and CC. In contrast, the mucosal up-regulation of MMP-9 correlated with the severity of inflammation in UC. The increased MMP-9 expression could contribute to the severity of mucosal damage in active UC.
引用
收藏
页码:85 / 91
页数:7
相关论文
共 39 条
[1]   Collagenous colitis evolving into ulcerative colitis: A case report and review of the literature [J].
Aqel, B ;
Bishop, M ;
Krishna, M ;
Cangemi, J .
DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (12) :2323-2327
[2]   DISTRIBUTION OF THE MATRIX METALLOPROTEINASES STROMELYSIN, GELATINASE-A AND GELATINASE-B, AND COLLAGENASE IN CROHNS-DISEASE AND NORMAL INTESTINE [J].
BAILEY, CJ ;
HEMBRY, RM ;
ALEXANDER, A ;
IRVING, MH ;
GRANT, ME ;
SHUTTLEWORTH, CA .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (02) :113-116
[3]   Matrix metalloproteinase levels are elevated in inflammatory bowel disease [J].
Baugh, MD ;
Perry, MJ ;
Hollander, AP ;
Davies, DR ;
Cross, SS ;
Lobo, AJ ;
Taylor, CJ ;
Evans, GS .
GASTROENTEROLOGY, 1999, 117 (04) :814-822
[4]   Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: Central role of epithelial-derived MMP [J].
Castaneda, FE ;
Walia, B ;
Vijay-Kumar, M ;
Patel, NR ;
Roser, S ;
Kolachala, VL ;
Rojas, M ;
Wang, LX ;
Oprea, G ;
Garg, P ;
Gewirtz, AT ;
Roman, J ;
Merlin, D ;
Sitaraman, SV .
GASTROENTEROLOGY, 2005, 129 (06) :1991-2008
[5]   Functional modulation of crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies [J].
Di Sabatino, Antonio ;
Pender, Sylvia L. F. ;
Jackson, Claire L. ;
Prothero, Joanna D. ;
Gordon, John N. ;
Picariello, Lucia ;
Rovedatti, Laura ;
Docena, Guillermo ;
Monteleone, Giovanni ;
Rampton, David S. ;
Tonelli, Francesco ;
Corazza, Gino R. ;
Macdonald, Thomas T. .
GASTROENTEROLOGY, 2007, 133 (01) :137-149
[6]   mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray [J].
Galamb, Orsolya ;
Sipos, Ferenc ;
Dinya, Elek ;
Spisak, Sandor ;
Tulassay, Zsolt ;
Molnar, Bela .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (43) :6998-7006
[7]   Expression of matrix metalloproteinases-2 and-9 in intestinal tissue of patients with inflammatory bowel diseases [J].
Gao, Q ;
Meijer, MJW ;
Kubben, FJGM ;
Sier, CFM ;
Kruidenier, L ;
van Duijn, W ;
van den Berg, M ;
van Hogezand, RA ;
Lamers, CBHW ;
Verspaget, HW .
DIGESTIVE AND LIVER DISEASE, 2005, 37 (08) :584-592
[8]   Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis [J].
Garg, Pallavi ;
Vijay-Kumar, Matam ;
Wang, Lixin ;
Gewirtz, Andrew T. ;
Merlin, Didier ;
Sitaraman, Shanthi V. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 296 (02) :G175-G184
[9]   Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel disease [J].
Gordon, John N. ;
Pickard, Karen M. ;
Di Sabatino, Antonio ;
Prothero, Joanna D. ;
Pender, Sylvia L. F. ;
Goggin, Patrick M. ;
MacDonald, Thomas T. .
INFLAMMATORY BOWEL DISEASES, 2008, 14 (02) :195-203
[10]  
Herszènyi L, 1999, CANCER, V86, P1135, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1135::AID-CNCR6>3.0.CO